论文部分内容阅读
目的观察康艾注射液治疗晚期癌症的临床疗效。方法 2008年8月至2010年5月无法耐受手术、放化疗的晚期癌症患者57例,随机分为两组,研究组30例采用康艾注射液加支持疗法治疗;对照组27例采用单纯支持疗法治疗。比较两组疼痛缓解程度及近期疗效。结果疼痛缓解率岩舒组为56.7%,对照组为37.0%,两组比较差异有统计学意义(P<0.05);近期疗效两组均无完全缓解或部分缓解病例,治疗组稳定率为76.7%,对照组为33.33%,两组比较差异有统计学意义(P<0.05)。结论康艾注射液具有减轻疼痛,提高患者的生活质量,延长生存期的作用。
Objective To observe the clinical effect of Kang Ai injection in the treatment of advanced cancer. Methods From August 2008 to May 2010, 57 patients with advanced cancer who could not tolerate surgery and radiotherapy and chemotherapy were randomly divided into two groups. The study group was treated with Kangai injection and supportive therapy. In the control group, 27 patients were treated with simple Support therapy treatment. The degree of pain relief and the recent curative effect were compared between the two groups. Results The pain relief rate was 56.7% in Yan Shu group and 37.0% in control group, with significant difference between the two groups (P <0.05). There was no complete remission or partial remission in both groups in the short term. The stability of the treatment group was 76.7% %, Control group was 33.33%, the difference between the two groups was statistically significant (P <0.05). Conclusions Kangai injection has the effect of relieving pain, improving patient’s quality of life and prolonging survival period.